Stem cell Immunology

In this regard, the field of oncology seems to be at an inflexion point: how do we identify and remove cancerous cells responsible for disease relapse, metastasis, and progression In addition, the understanding and utilization of normal hematopoietic and lymphoid stem cells could open alternate avenues to more effectively re-engineer and direct T cells against CSCs.  Cancer “stem cells” as a new category of targets for immune intervention, for both solid and hematologic malignancies. Therapeutic platforms based on stem cells: hematopoietic stem cells, reprogrammed pluripotent stem cells, stem cell-like memory T cells and tumor-derived stem cells.


  • Embryonic stem cells. Embryonic stem cells come from human embryos that are three to five days old
  • Non-embryonic (adult) stem cells
  • Induced pluripotent stem cells
  • Cord blood stem cells and amniotic fluid stem cells

Related Conference of Stem cell Immunology

March 18-19, 2021

3rd World Conference on Vaccine and Immunology

Dubai, UAE
March 24-24, 2021

3rd International Conference on Dermatology and Allergic Diseases

Singapore City, Singapore
April 15-16, 2021

Tumor & Cancer Immunology and Pediatric-Oncology

Toronto, Canada
April 19-20, 2021

9th World Summit on immunology & immunotherapy

Prague, Czech Republic
May 03-04, 2021

International Online Conference on Immunology

New York, USA
June 23-24, 2021

34th World Congress on Vaccines and Immunization

Osaka, Australia
October 12-13, 2021

International Conference on Vaccine and Vaccine research

Manila, Philippines
October 14-15, 2021

13th Annual Conference on Cinical Immunology

Cape Town, Australia
October 14-15, 2021

11th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa

Stem cell Immunology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in